How XALATAN Works
High eye pressure is a serious condition that can cause vision loss. One dose of XALATAN each day can reduce eye pressure. Reducing eye pressure has been shown to reduce the risk of vision loss from glaucoma.
How XALATAN lowers eye pressure
XALATAN works by helping to open drainage channels in your eyes. This allows excess fluid to drain. In turn, the pressure in your eyes drops.
Your eyes are naturally filled with a watery fluid. New fluid is always being produced by your body while the old fluid is draining out.
But if your drainage channels don’t work well, the fluid begins to build up. If this happens the pressure inside your eyes will rise. You usually can’t feel this pressure, but it can cause damage to the optic nerve and lead to permanent vision loss.
XALATAN works by unclogging the drainage channels, reducing the pressure in your eyes.
If you have high eye pressure, talk to your eye doctor.
Watch this video to learn more about how XALATAN works.
This video requires a Flash player and JavaScript. If you don't have the latest version, you can download the player free of charge.
Next Section: Possible Side Effects
Eyedrop Tips
Indication
XALATAN is for the treatment of high eye pressure/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.
Important Safety Information
Like all medicines, XALATAN can have side effects. These side effects are usually mild and tolerable and may include blurred vision, burning and stinging, eye redness, the feeling of something in the eye, eye itching, increased pigmentation (darkening) of eye color, or irritation of the clear front surface of the eye.
XALATAN may slowly cause darkening of the eye color due to increased brown color, darkening of the eyelid and eyelashes, and increased growth and thickness of eyelashes. Color changes can increase as long as XALATAN is administered and eye color changes are likely to be permanent.
The recommended dosage is one drop (1.5 µg) in the affected eye(s) once daily in the evening. If one dose is missed, treatment should continue with the next dose as normal.
There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.
Pfizer is a licensee of the TRUSTe Privacy Program.© 2009 Pfizer Inc. All rights reserved.
XLU00691 D